CRBU - Caribou Biosciences, Inc.
IEX Last Trade
1.655
0.020 1.208%
Share volume: 26,405
Last Updated: Fri 27 Dec 2024 08:30:06 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$1.64
0.02
1.22%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-08 | 2023-03-09 | 2023-05-09 | 2023-08-08 | 2023-11-07 | 2024-03-11 | 2024-05-07 | |
| Total revenue | 4.192 M | 3.303 M | 3.692 M | 3.502 M | 3.755 M | 23.662 M | 3.558 M | 2.429 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 4.192 M | 3.303 M | 3.692 M | 3.502 M | 3.755 M | 23.662 M | 3.558 M | 2.429 M | |
| -21.21% | 11.78% | -5.15% | 7.22% | 530.15% | -84.96% | -31.73% | |||
| Operating expenses | 32.623 M | 29.840 M | 34.270 M | 34.618 M | 36.623 M | 38.295 M | 41.000 M | 48.431 M | |
| Selling general and admin | 10.044 M | 9.849 M | 8.534 M | 8.909 M | 10.120 M | 9.711 M | 9.721 M | 14.643 M | |
| Research and development | 22.579 M | 19.991 M | 25.736 M | 25.709 M | 26.503 M | 28.584 M | 31.279 M | 33.788 M | |
| Total expenses | 32.623 M | 29.840 M | 34.270 M | 34.618 M | 36.623 M | 38.295 M | 41.000 M | 48.431 M | |
| -8.53% | 14.85% | 1.02% | 5.79% | 4.57% | 7.06% | 18.12% | |||
| Operating income | -28.431 M | -26.537 M | -30.578 M | -31.116 M | -32.868 M | -14.633 M | -37.442 M | -46.002 M | |
| Ebit | -28.431 M | -26.537 M | -30.578 M | -31.116 M | -32.868 M | -14.633 M | -37.442 M | -46.002 M | |
| Pretax income | -26.697 M | -26.647 M | -26.919 M | -28.044 M | -29.519 M | -10.002 M | -34.312 M | -41.234 M | |
| -0.19% | 1.02% | 4.18% | 5.26% | -66.12% | 243.05% | 20.17% | |||
| Income tax | 0.000 | 0.000 | 70.000 K | 0.000 | 0.000 | 0.000 | 193.000 K | 0.000 | |
| Net income basic | -27.189 M | -27.101 M | -25.089 M | -27.256 M | -29.925 M | -10.002 M | -34.505 M | -41.234 M | |
| 0.32% | 7.42% | -8.64% | -9.79% | 66.58% | -244.98% | -19.50% | |||
| Net income | -27.189 M | -27.101 M | -25.089 M | -27.256 M | -29.925 M | -10.002 M | -34.505 M | -41.234 M | |
| 0.32% | 7.42% | -8.64% | -9.79% | 66.58% | -244.98% | -19.50% |